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Abstract
Background: There currently is a severe Zika Virus (ZIKV) epidemic in Brazil and other South American countries.
Due to international travel, this poses severe public health risk of ZIKV importation to other countries. We estimate
the prevalence of ZIKV in an import region by the time a microcephaly case is detected, since microcephaly is
presently the most significant indication of ZIKV presence.
Methods: We establish a mathematical model to describe ZIKV spread from a source region to an import region.
This model incorporates both vector transmission (between humans and mosquitoes) and sexual transmission
(from males to females). We take account of population structure through a contact network for sexually active
individuals. Parameter values of our model are either taken from the literature or estimated from travel data.
Results: This model gives us the probability distribution of time until detection of the first microcephaly case.
Based on current field observations, our results also indicate that the percentage of infected pregnant women that
results in fetal abnormalities is more likely to be on the smaller end of the 1%–30% spectrum that is currently
hypothesized. Our model predicts that for import regions with at least 250,000 people, on average 1,000–12,000 will
have been infected by the time of the first detection of microcephaly, and on average 200–1,500 will be infectious
at this time. Larger population sizes do not significantly change our predictions.
Conclusions: By the first detection of a microcephaly case, a sizable fraction of the population will have been
infected by ZIKV. It is thus clear that adequate surveillance, isolation, and quarantine are needed in susceptible
import regions to stop the dissemination of a Zika epidemic.
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network
Background
In March 2015, an outbreak of Zika virus (hereafter
referred to as ZIKV) was discovered in Bahia, Brazil [1].
Recent findings [2] attribute the introduction of ZIKV in
Brazil to a single imported infection, estimated to be
during the latter half of 2013. This outbreak is currently
ongoing with public health efforts to mitigate the disper-
sal of ZIKV throughout other populations. Recent ZIKV
outbreaks before the current outbreak in Brazil include
outbreaks in Pacific Islands, such as in 2007 in Yap
Island, Micronesia [3] and in 2013 in French Polynesia
[4]. Currently, there are two main strains of ZIKV,
namely an African lineage and an Asian lineage [5].
Acute ZIKV infections in humans may result in fever,
macopapular rash, conjunctivitis, muscle pain and joint
aches [6]. These symptoms of ZIKV infections are usu-
ally mild and difficult to differentiate from other viral in-
fections thus resulting in vast underreporting of ZIKV
cases. However, epidemiological studies of recent out-
breaks of ZIKV indicate associations between ZIKV and
neurological disorders, especially microcephaly and sig-
nificant brain anomalies in fetuses of infected pregnant
females [7]. This has been confirmed during both the
French Polynesia outbreak [8] and the current outbreak
in Brazil [9]; see [10] and [11] for specific cases of fetal
abnormalities during infected pregnancies. In addition,
both the infection by the Brazilian strain [12] and the
infection by the SZ01 Asian strain [13] have been
demonstrated to cause microcephaly in mice fetuses.
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For a population that is not under active surveil-
lance, an abnormal fetus is very likely the first indica-
tion of a ZIKV epidemic in the population. However,
starting from the importation of ZIKV into a popula-
tion, it may take some time for ZIKV to infect a
pregnant female due to the low fraction of such fe-
males in the population (approximately 1% in the
United States [14]). Moreover, only infections in their
first trimester are more likely to result in an in-
creased risk for fetal abnormality such as microceph-
aly [8], and such an abnormal fetus can be detected
at roughly 20 weeks [11]. Thus, by the time a micro-
cephaly case is detected, ZIKV could have spread in
the population for a long time, and caused an epi-
demic. Estimates of the final size of ZIKV epidemics
on Yap Island and in French Polynesia are 73% and
66%, respectively [3, 8], showing that a significant
proportion of individuals in a susceptible population
become infected with ZIKV during an outbreak. In
conjunction with the association of ZIKV with neuro-
logical disorders, these percentages indicate potential
repercussions on a large scale.
In this paper, we quantify the prevalence and total
infections of ZIKV in a region (e.g., a city, a state or a
country) at the time of the first detection of microceph-
aly, estimates that are crucial for public health planning
at the start of a ZIKV outbreak.
Methods
We develop a mathematical model for the spread of
ZIKV, which is transmitted to humans by mosquitoes of
the Aedes genus; for e.g., A. aegypti, A. albopictus and A.
africanus mosquitoes [15]. These mosquitoes also trans-
mit yellow fever, dengue and chikungunya. Mathematical
models for these vector transmitted diseases have been
extensively studied [16, 17]. However, ZIKV can also be
transmitted through sexual contact from an infected
male to a susceptible female [15, 18–20]. In fact, ZIKV
persists in semen much longer than in blood and other
bodily fluids [21]. Thus vector transmission may have a
shorter infectious period than sexual transmission.
Recovery after infection seems to confer long-term
immunity for individuals [22]. There currently exist no
cure, no treatment, and no vaccine for ZIKV. This
effectively renders every individual that has not
contracted ZIKV a susceptible one, and indicates a large
potential for the dissemination of ZIKV through human
populations.
Our mathematical model considers two regions to
incorporate the importation of cases from a “source”
region (Region 1) experiencing an epidemic into a
completely susceptible “import” region (Region 2). Figure 1
illustrates our model for the transmission of ZIKV in two
regions, and Table 1 summarizes parameter values and
their ranges; see Additional file 1: for justification of the
model and of parameter values.
The time to the first infection Tp of a pregnant female
in Region 2 can be estimated from this model. New
cases per day in pregnant females that result in micro-
cephaly can be modeled as a non-homogeneous Poisson
process with rate
λ(t) = − p × z × (rate of change of susceptible sexually
active females in Region 2),
where p is the proportion of pregnant females in
the sexually active female population and z is the
proportion of pregnancies that are affected by ZIKV
and result in fetal abnormalities. The probability
density function for Tp is λ(t)exp(∫o
t λ(τ)dτ). For ex-
ample, 1% of the US population are pregnant females
[14], which corresponds to p = 3% since 1/3 of the
population is sexually active females. It is estimated
that z = 29% in Brazil [9], whereas it is estimated that
z = 1% based on data from the ZIKV outbreak in
French Polynesia [8].
The time to the first detection of a microcephaly case
Td can then be computed by adding the delay from the
Table 1 Parameter definitions, values and ranges for two-region model
Parameter Definition (time-1) Estimated baseline
value (day-1)
Range (day-1) Source
βV 1H1 ; βV2H2 Transmission rate, mosquitoes to humans within region 0.105 0.0975 to 0.1125 [17]
βH 1 V1 ; βH2V2 Transmission rate, humans to mosquitoes within region 0.105 0.0975 to 0.1125 [17]
βV 1H2 ; βV2H1 Transmission rate, mosquitoes to humans between regions 0.00003 0.00003 to 0.00006 Estimated (TA, Additional file 1),
[17, 29]
βH 1 V2 ; βH2V1 Transmission rate, humans to mosquitoes between regions 0.00003 0.00003 to 0.00006 Estimated (TA, Additional file 1),
[17, 29]
1/ γB Mean infectious period from blood 7 4 to 11 [30]
1/ γB + 1/ γB Mean infectious period from semen 62 57 to 67 [21, 30]
βM1F1 ; βM2F2 Transmission rate, males to females within region 0.5 0.3 to 0.7 Estimated
βM1F2 ; βM2F1 Transmission rate, males to females between region 0.01 0.005-0.105 Estimated
d Death rate of mosquitoes 1/50 [31]
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infection of a pregnant female to the detection of abnor-
mality in the fetus. Fetal abnormality most likely results
from ZIKV infection in the first trimester, as shown in
the 2013-2014 outbreak of ZIKV in French Polynesia [8].
Because the infection of the mother can occur any time
during her pregnancy, by the detection at 20 weeks, i.e.,
140 days [11], Td = Tp + 140 − Tf where Tf is a uniformly
distributed random infection time between 0 and 84 days
(i.e., during the first trimester).
Numerically simulating our model to the time of the
first microcephaly detection Td yields the prevalence of
ZIKV in the import region at that time. The simulations
are done using baseline parameter values as in Table 1,
and with the random network distributions for sexually
active males and females in the same region being Pois-
son with mean 2.25, and for males and females of differ-
ent regions being Poisson with mean 0.1. These values
are chosen so that the resulting basic reproduction num-
ber R0 and final size agree with literature values; see the
Results section. We assume that the population of
Region 1 is 2 million and that initially one person in
Region 1 is infectious, while all other people and all
mosquitoes in Regions 1 and 2 are susceptible.
The uncertainty in parameter values in Table 1 is
incorporated in the simulations using the Latin Hyper-
cube Sampling (LHS) maximin criteria [23], assuming all
parameters except the death rate of mosquitoes d have
uniform distributions with ranges given in Table 1, and
1/d is normally distributed with mean μ = 50 days and
standard deviation σ = 3 days. For estimating Tp and Td
distributions, we sample 2,000 points from the LH
parameter space. For prevalence and total case estimates
in the import region, we sample 100 points in the LH
parameter space, and for each point selected, we com-
pute the probability density function of the time until
detection of ZIKV and sample a further 100 points from
this distribution. We select LH data that gives rise to
ZIKV epidemics with a least 1 pregnant female in a
population of 2 million.
Results
The basic reproduction number R0 is computed for the
baseline parameters in Table 1: R0 ≈ 1.4 (TA, Additional
file 1), agreeing with other estimated values [24]. For
these parameters, the final sizes of the outbreaks in Re-
gions 1 and 2 are numerically calculated to be 63.95%
and 64.66%, respectively. These values are near the re-
ported final sizes of outbreaks on Yap Island in 2007 and
French Polynesia in 2013-2014.
For a range of z values, Fig. 2a shows box plots of the
length of time until a pregnant female contracts ZIKV
and passes it on to her fetus for population sizes in Re-
gion 2 ranging from 0.25 to 2 million. This median time
lies between 525 and 800 days, depending on population
size and z values. Figure 2b shows the box plots of the
time to the first microcephaly detection for the same set-
tings as used in Fig. 2a, giving a median time lying
between 625 and 900 days. For every doubling of popu-
lation size, both median times go down by at most
30 days.
Based on our sensitivity analysis procedure, we present
in Fig. 3a boxplots of the 10,000 data points of preva-
lence (number of infectious individuals) at the time of
detection Td in the import region (Region 2) for fixed z
values, and in Fig. 3b boxplots of 10,000 data points of
the total cases by Td in the import region for fixed z
values. In Fig. 3a and b the populations of the import
region are fixed at 0.25, 0.5, 1, and 2 million, whereas
that of the source region remains at 2 million. Figure 3
shows that by the time a microcephaly case is detected in
an import region with a population of at least 250,000, the
median prevalence of ZIKV ranges from 200-1,500, and
Fig. 1 Flowchart of two-region model for ZIKV transmission with vectors V, males M, females F, sexually inactive humans N, and subscripts
representing regions. The solid lines represent contacts within a region, and dashed curves represent contacts between regions
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the median total infected ranges from 1,000-12,000.
Larger population sizes do not significantly change these
predictions.
Discussion
In order to quantify ZIKV transmission from a source
region to an import region, we formulated a mathemat-
ical model for the transmission of ZIKV in two regions.
As in other ZIKV models [24, 25], we incorporate in our
model vector transmission (between mosquitoes and
humans), and sexual transmission (from sexually active
males to females). We take account of population struc-
ture through a contact network for sexually active indi-
viduals, which is more realistic than the homogeneous
mixing assumption of other models [24, 25]. Using data
from the literature and estimated from travel, we obtain
Fig. 3 a. Prevalence of ZIKV at the time of detection as a function of the fraction of pregnancies that are affected by ZIKV. One hundred points
are sampled (by LHS maximin criteria) from parameter values in Table 1 as well as z, assuming all parameters but d follow uniform distributions,
and d ~ N(μ = 50,σ = 3). For every point, 100 subsequent points are selected randomly from the probability density function of the time until
detection, and the prevalence at each of the 10,000 points is computed for each population size. These data points are summarized in boxplots.
Note that the upper whisker of the boxplot for z = 0.01 with 2 million people extends to about 14,000 but is not shown in its entirety. For z =
0.01 with 0.25, 0.5 and 1 million people, and for z = 0.05 with 0.25 million people, we omit parameter sets in the LH for which microcephaly may
not occur during an epidemic. b. Using the same sampling procedure as in a, total cases by the time of detection in the second region are
determined as a function of z, and results are also presented in boxplots. Note that the upper whisker of the boxplot for z = 0.01 with 2 million
people extends to about 70,000 but is not shown in its entirety. In both a and b, upper whiskers for all populations with z = 0.01 are not
completely shown, and outliers are not plotted
Fig. 2 a. Time until the first pregnant female contracts ZIKV and passes it on to her fetus (Tp). b. Time until detection of a ZIKV outbreak (Td).
Here, z is the proportion of pregnancies resulting in abnormalities from ZIKV and Region 1 has a population of 2 million
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the probability distributions of the time to the
detection of microcephaly Td in the import region for
various population sizes. Based on this, we compute
the prevalence at detection of microcephaly in an
import region. Our method for estimating Td can be
adapted to other models of diseases that cause micro-
cephaly or other neurological disorders in a fetus, for
example, rubella.
Our values of Td presented in Fig. 3b agree with
the recent identification of microcephaly in a region
in Colombia around March 2016 [26] as it is likely
that a single infectious individual was responsible for
the spread of ZIKV from Asia to Brazil in the second
half of 2013 [2], corresponding to a time delay of
about 800 days from the arrival of ZIKV in the
source region to the detection of fetal abnormalities
in a fetus in the import region in Colombia. Based on
the time until microcephaly was observed in Columbia,
our results on Td in Fig. 2a indicate it is more likely that
the percentage of infected pregnancies is between 1%
and 10%.
From our model estimates, upon detection of micro-
cephaly in a region with a population of at least 250,000
people, on average 1,000–12,000 will have been infected,
and on average 200–1,500 will be infectious at this time.
Thus, it is imperative that potential import regions
monitor for ZIKV infections at all times. If indeed 1% ≤
z ≤ 10%, total cases and prevalences are more likely to
be on the higher end of the reported ranges, indicating
even greater local dissemination of ZIKV, and a greater
public health issue.
ZIKV may be also linked to Guillain-Barré Syndrome
(GBS) and other neurological syndromes [27]. However,
GBS may arise from many other causes [28]. These
syndromes may have higher prevalences and shorter
delays of onset than microcephaly. Thus our model sug-
gests that monitoring for these syndromes seems to be
beneficial for early detection of ZIKV, provided the link
between ZIKV and GBS is established and quantified.
Currently, detecting ZIKV by GBS cases may be less
reliable than by microcephaly.
Conclusions
Through simulations of our model, we have shown that
by the first detection of a microcephaly case, or similar
fetal abnormalities, a sizable fraction (between 0.4% and
4.8%) of the population will have been infected by ZIKV.
This makes controlling of local ZIKV spread very
difficult. It is thus important for public health agencies
to adopt surveillance (and possibly quarantine and
isolation) measures to travelers from a region with an
ongoing epidemic to avoid severe threats of ZIKV
importation.
Additional file
Additional file 1: This file contains the main methods that are involved
in the model formulation and the estimation of parameters. This file also
contains the technical details relating to the computation of the basic
reproduction number R0. (DOCX 139 kb)
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Article summary
We predict that by the detection of the first case of microcephaly in a
region, a significant number of people will have been infected with Zika
virus, posing a significant public health threat.
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